128 related articles for article (PubMed ID: 11807604)
1. Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration on the pharmacokinetics.
Wester HJ; Schottelius M; Scheidhauer K; Reubi JC; Wolf I; Schwaiger M
Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):28-38. PubMed ID: 11807604
[TBL] [Abstract][Full Text] [Related]
2. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.
Schottelius M; Rau F; Reubi JC; Schwaiger M; Wester HJ
Bioconjug Chem; 2005; 16(2):429-37. PubMed ID: 15769098
[TBL] [Abstract][Full Text] [Related]
3. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide.
Wester HJ; Schottelius M; Scheidhauer K; Meisetschläger G; Herz M; Rau FC; Reubi JC; Schwaiger M
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):117-22. PubMed ID: 12483418
[TBL] [Abstract][Full Text] [Related]
4. Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydrates.
Schottelius M; Wester HJ; Reubi JC; Senekowitsch-Schmidtke R; Schwaiger M
Bioconjug Chem; 2002; 13(5):1021-30. PubMed ID: 12236784
[TBL] [Abstract][Full Text] [Related]
5. Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts.
Vaidyanathan G; Friedman HS; Affleck DJ; Schottelius M; Wester HJ; Zalutsky MR
Clin Cancer Res; 2003 May; 9(5):1868-76. PubMed ID: 12738745
[TBL] [Abstract][Full Text] [Related]
6. [123I]Mtr-TOCA, a radioiodinated and carbohydrated analogue of octreotide: scintigraphic comparison with [111In]octreotide.
Stahl A; Meisetschläger G; Schottelius M; Bruus-Jensen K; Wolf I; Scheidhauer K; Schwaiger M
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):45-52. PubMed ID: 16151771
[TBL] [Abstract][Full Text] [Related]
7. N-terminal sugar conjugation and C-terminal Thr-for-Thr(ol) exchange in radioiodinated Tyr3-octreotide: effect on cellular ligand trafficking in vitro and tumor accumulation in vivo.
Schottelius M; Reubi JC; Eltschinger V; Schwaiger M; Wester HJ
J Med Chem; 2005 Apr; 48(8):2778-89. PubMed ID: 15828816
[TBL] [Abstract][Full Text] [Related]
8. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.
Schottelius M; Poethko T; Herz M; Reubi JC; Kessler H; Schwaiger M; Wester HJ
Clin Cancer Res; 2004 Jun; 10(11):3593-606. PubMed ID: 15173065
[TBL] [Abstract][Full Text] [Related]
9. Targeting somatostatin receptors: preclinical evaluation of novel 18F-fluoroethyltriazole-Tyr3-octreotate analogs for PET.
Leyton J; Iddon L; Perumal M; Indrevoll B; Glaser M; Robins E; George AJ; Cuthbertson A; Luthra SK; Aboagye EO
J Nucl Med; 2011 Sep; 52(9):1441-8. PubMed ID: 21852355
[TBL] [Abstract][Full Text] [Related]
10. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
Capello A; Krenning E; Bernard B; Reubi JC; Breeman W; de Jong M
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
[TBL] [Abstract][Full Text] [Related]
11. Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide.
Meisetschläger G; Poethko T; Stahl A; Wolf I; Scheidhauer K; Schottelius M; Herz M; Wester HJ; Schwaiger M
J Nucl Med; 2006 Apr; 47(4):566-73. PubMed ID: 16595488
[TBL] [Abstract][Full Text] [Related]
12. [(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate.
Maina T; Nock BA; Cordopatis P; Bernard BF; Breeman WA; van Gameren A; van den Berg R; Reubi JC; Krenning EP; de Jong M
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):831-40. PubMed ID: 16568203
[TBL] [Abstract][Full Text] [Related]
13. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.
Wild D; Schmitt JS; Ginj M; Mäcke HR; Bernard BF; Krenning E; De Jong M; Wenger S; Reubi JC
Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1338-47. PubMed ID: 12937948
[TBL] [Abstract][Full Text] [Related]
14. Proof of principle for the use of 11C-labelled peptides in tumour diagnosis with PET.
Henriksen G; Schottelius M; Poethko T; Hauser A; Wolf I; Schwaiger M; Wester HJ
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1653-7. PubMed ID: 15309330
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide.
Decristoforo C; Melendez-Alafort L; Sosabowski JK; Mather SJ
J Nucl Med; 2000 Jun; 41(6):1114-9. PubMed ID: 10855644
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of glycosylated octreotate analogues labeled with radioiodine and 211At via a tin precursor.
Vaidyanathan G; Affleck DJ; Schottelius M; Wester H; Friedman HS; Zalutsky MR
Bioconjug Chem; 2006; 17(1):195-203. PubMed ID: 16417269
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT.
Virgolini I; Angelberger P; Li S; Yang Q; Kurtaran A; Raderer M; Neuhold N; Kaserer K; Leimer M; Peck-Radosavljevic M; Scheithauer W; Niederle B; Eichler HG; Valent P
Eur J Nucl Med; 1996 Oct; 23(10):1388-99. PubMed ID: 8781146
[TBL] [Abstract][Full Text] [Related]
18. Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount.
de Jong M; Breeman WA; Bernard BF; van Gameren A; de Bruin E; Bakker WH; van der Pluijm ME; Visser TJ; Mäcke HR; Krenning EP
Eur J Nucl Med; 1999 Jul; 26(7):693-8. PubMed ID: 10398816
[TBL] [Abstract][Full Text] [Related]
19. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use.
Reubi JC; Schär JC; Waser B; Wenger S; Heppeler A; Schmitt JS; Mäcke HR
Eur J Nucl Med; 2000 Mar; 27(3):273-82. PubMed ID: 10774879
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy.
Wang X; Fani M; Schulz S; Rivier J; Reubi JC; Maecke HR
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1876-85. PubMed ID: 22926735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
